It appears the proposed health care reform bills encouraging drug companies to increase prices ahead of passage. The New York Times reports in “Rising Prices of Drugs Lead to Call for Inquiry” that the following Congressmen have written a letters to the General Accounting Office (GAO) asking for a review: Charles B. Rangel of New York, chairman of the Ways and Means Committee; Henry A. Waxman of California, chairman of the Energy and Commerce Committee; and Pete Stark of California, and John Lewis of Georgia, chairmen of two Ways and Means subcommittees.
Senator Bill Nelson of Florida has also written to the inspector general of the Department of Health and Human Services seeking an investigation.